Quantum-Si incorporated (QSI)
Quantum-Si incorporated operates in the Biotechnology industry of the Healthcare sector, headquartered in Branford, CT, US. The stock last traded at $0.82, up 3.81% on the session, giving a market capitalisation of $162.3M. On trailing twelve-month figures it carries a trailing P/E of -1.60, a net margin of -5605.9%. Its beta of 3.25 implies it has historically moved more than the broad market.
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Quantum-Si incorporated is most often compared with the following Healthcare names: